Eli Lilly (LLY) recently entered a collaboration with Gate Bioscience to develop molecular gate therapeutics, a move that ...

Under the terms of the agreement, Gate will receive an upfront payment and equity investment and will be eligible to receive milestone payments upon achievement of certain develop ...

Eli Lilly (LLY) recently received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for its ...

California’s Gate Bioscience, a biotech developing molecular gates, a new class of small molecule drugs to eliminate ...

Eli Lilly is walking through the Gate, inking a deal worth up to $856 million with a biotech aiming to build out a new ...

Gate Bioscience Inc. has entered a collaboration and license agreement with Eli Lilly and Co. to discover, develop and ...

Anthem Biosciences listed at a 27% premium, attracting strong investor interest. Meanwhile, Spunweb Nonwoven soared 57% on its debut on the NSE Emerge platform.

The gene therapy developer is cutting 30% of its workforce. Elsewhere, Abivax secured a major cash infusion, while Novartis and Eli Lilly struck small research deals.

Despite AI's potential to transform the work landscape, Bill Gates asserts that some professions will become increasingly ...

Instead, Gate Bioscience is developing molecular gates that can eliminate disease-causing extracellular proteins before they leave the cell.

Colossal Biosciences shared an update on the dire wolves they brought back from extinction; three pups, Romulus, Remus, and Khaleesi, that have doubled in size over the past 6 months ...